Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab

The treatment of advanced non-small cell lung cancer (NSCLC) has been revolutionized by immune checkpoint inhibitors (ICIs). The identification of prognostic and predictive factors in ICIs-treated patients is presently challenging. Circulating tumor cells (CTCs) and cell-free DNA (cfDNA) were evalua...

Full description

Bibliographic Details
Main Authors: Angela Alama, Simona Coco, Carlo Genova, Giovanni Rossi, Vincenzo Fontana, Marco Tagliamento, Maria Giovanna Dal Bello, Alessandra Rosa, Simona Boccardo, Erika Rijavec, Federica Biello, Luca Longo, Zita Cavalieri, Cristina Bruzzo, Francesco Grossi
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Journal of Clinical Medicine
Subjects:
liquid biopsy
lung cancer
circulating tumor cells
cell-free DNA
immune checkpoint inhibitors
nivolumab
prognosis
Online Access:https://www.mdpi.com/2077-0383/8/7/1011

Internet

https://www.mdpi.com/2077-0383/8/7/1011

Similar Items